Trials / Conditions / Generalized Epilepsy

Generalized Epilepsy

11 registered clinical trials studyying Generalized Epilepsy.

Status	Trial	Sponsor	Phase
Terminated	A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Gen NCT06425159	Biohaven Therapeutics Ltd.	Phase 2 / Phase 3
Completed	Assessment of Multifocal Continuous Theta Burst Transcranial Magnetic Stimulation (cTBS) Effects in Generalize NCT06797791	Universitatea de Stat de Medicina si Farmacie Nicolae Testemiţanu	N/A
Terminated	Long-term Cardiac Monitoring in Epilepsy NCT03955432	Northwell Health	N/A
Completed	Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epile NCT03590197	All India Institute of Medical Sciences, Bhubaneswar	Phase 4
Withdrawn	Transcranial Direct Current Stimulation (tDCS) in Children and Adolescents With Epilepsy and Depression NCT03368469	Mayo Clinic	N/A
Unknown	Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong NCT03457961	Chinese University of Hong Kong	—
Completed	Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy NCT01311440	Oslo University Hospital	N/A
Completed	Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients NCT04965571	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Completed	Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy NCT00150735	UCB Pharma	Phase 3
Completed	Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy NCT00150748	UCB Pharma SA	Phase 3
Completed	Metabolic Abnormalities in Children With Epilepsy NCT00001325	National Institute of Neurological Disorders and Stroke (NINDS)	—